Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

COVID-19 forecasting from U.S. wastewater surveillance data: A retrospective multi-model study (2022-2024).

Journal of theoretical biology·2026

Same author

Effect of Preventive Measures and Heterogeneity of Sexual Contacts on Zika virus Transmission.

Bulletin of mathematical biology·2026

Same author

Improving Wolbachia-based control programs in urban settings: Insights from spatial modeling.

PLoS neglected tropical diseases·2025

Same author

Computational Properties of the Prefrontal Cortex.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025

Same author

ACC Reward Location Information Is Carried by Hippocampal Theta Synchrony and Suppressed in a Type 2 Diabetes Model.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025

Same author

ELISA protein detector (EPD): A Python-based ELISA tool for accurate low-level protein quantification.

Journal of immunological methods·2025

Search research articles

Related Experiment Video

Updated: Jul 26, 2025

Author Spotlight: Investigating the Effects of Mind-Body-Movement Practices on Brain Function

Author Spotlight: Investigating the Effects of Mind-Body-Movement Practices on Brain Function

Published on: January 26, 2024

Spatial navigation: Alzheimer's pathology disrupts movement-based navigation.

Guncha Bhasin¹, Kirsten N Calvin-Dunn², James M Hyman¹

¹Department of Psychology, University of Nevada Las Vegas, 4540 S. Maryland Pkwy, Las Vegas, NV 89154, USA.

Current Biology : CB

|June 20, 2023

Summary

This summary is machine-generated.

Animals navigate using movement-based and landmark-based strategies. A study shows impaired movement-based navigation disrupts grid cell activity in an early Alzheimer

More Related Videos

Modeling the Functional Network for Spatial Navigation in the Human Brain

Modeling the Functional Network for Spatial Navigation in the Human Brain

Published on: October 13, 2023

A Video Demonstration of Preserved Piloting by Scent Tracking but Impaired Dead Reckoning After Fimbria-Fornix Lesions in the Rat

A Video Demonstration of Preserved Piloting by Scent Tracking but Impaired Dead Reckoning After Fimbria-Fornix Lesions in the Rat

Published on: April 24, 2009

Related Experiment Videos

Last Updated: Jul 26, 2025

Author Spotlight: Investigating the Effects of Mind-Body-Movement Practices on Brain Function

Author Spotlight: Investigating the Effects of Mind-Body-Movement Practices on Brain Function

Published on: January 26, 2024

Modeling the Functional Network for Spatial Navigation in the Human Brain

Modeling the Functional Network for Spatial Navigation in the Human Brain

Published on: October 13, 2023

A Video Demonstration of Preserved Piloting by Scent Tracking but Impaired Dead Reckoning After Fimbria-Fornix Lesions in the Rat

A Video Demonstration of Preserved Piloting by Scent Tracking but Impaired Dead Reckoning After Fimbria-Fornix Lesions in the Rat

Published on: April 24, 2009

Area of Science:

Neuroscience
Animal Behavior
Alzheimer's Disease Research

Background:

Animals utilize both idiothetic (movement-based) and allothetic (landmark-based) navigation strategies.
Grid cells are crucial for spatial navigation and are implicated in Alzheimer's disease.

Purpose of the Study:

To investigate the role of idiothetic navigation in grid cell dysfunction in early Alzheimer's disease.

Main Methods:

Utilized an early-stage Alzheimer's disease mouse model.
Assessed idiothetic navigation capabilities.
Examined grid cell coding patterns.

Main Results:

Compromised idiothetic navigation was observed in the Alzheimer's model.
Disrupted grid cell coding was directly linked to impaired idiothetic navigation.

Conclusions:

Impaired movement-based navigation is an early indicator of grid cell dysfunction in Alzheimer's disease.
This finding highlights a potential therapeutic target for spatial memory deficits in Alzheimer's.